Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Clinical trial NCT07349537 · RECRUITING

Trial details

NCT number: NCT07349537
Sponsor: Revolution Medicines, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Adenocarcinoma Pancreatic Ductal Adenocarcinoma (PDAC)PDAC CRC NSCLC Pancreatic Cancer Lung Cancer (NSCLC)Advanced Solid Tumors

Start date: 2026-01-08
Primary completion: 2028-04-01
Enrollment: 574

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.